Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 44 for “"SERUM PHOSPHATE"”.
-
Evaluation of phosphate knowledge and the effectiveness of a phosphate management protocol to achieve optimum serum phosphate levels in haemodialysis patients
… designed to achieve and maintain acceptable serum phosphate levels, current prevalence rates of hyperphosphataemia and associated health risks, in haemodialysis patients indicate that controlling serum phosphate levels remains a challenge in the 21st century. The aims of this study were to …
-
ΒΙΟΧΗΜΙΚΗ ΚΑΙ ΑΝΟΣΟΛΟΓΙΚΗ ΜΕΛΕΤΗ ΔΙΑΓΝΩΣΤΙΚΩΝ ΠΑΡΑΜΕΤΡΩΝ ΣΕ ΠΑΣΧΟΝΤΕΣ ΑΠΟ ΟΞΕΙΑ ΜΥΕΛΟΓΕΝΗ ΛΕΥΧΑΙΜΙΑ
THE PRESENT STUDY ISOLATED CONCENTRATION OF SERUM FERRITIN, SERUM GALACTIC DEHYDROGENASE, SERUM ALKALINE PHOSPHATASE, SERUM CALCIUM AND SERUM PHOSPHATE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA PRIOR AND AFTER CHEMOTHERAPY APPLICATION. RESULTS EVALUATION INDICATE THE FOLLOWING. 1) SERUM FERRITIN …
-
TRANSLATIONAL CHARACTERIZATION OF ACUTE PHOSPHATE DISPOSITION AS IT RELATES TO BONE AND MINERAL HOMEOSTASIS AND CHRONIC KIDNEY DISEASE
Elevated serum phosphate is an independent risk factor for cardiovascular disease (CVD) in the general population, and this elevated risk is most prominent in the setting of chronic kidney disease (CKD). Dysregulation of mineral homeostasis is a hallmark of progressing CKD, however serum phosphate …
-
The Effect of Preeclampsia on Renal Function: Cross-Sectional Studies of Postpartum Preeclamptics and Women Who Were Destined to Develop Preeclampsia
… later in life. Mineral metabolism, such as phosphate balance is heavily dependent on renal function, yet, phosphate handling in women with a history of PE is largely unknown. To investigate whether women with a history of PE would exhibit changes in phosphate metabolism compared to healthy …
-
The Role of the Bone Mineral Axis in Non-Uraemic Vascular Disease
Higher serum phosphate concentration and dietary phosphate intake are independent predictors of cardiovascular mortality. Variations in the hormones that regulate serum phosphate (higher fibroblast growth factor-23 and parathyroid hormone, lower active vitamin D) also predict adverse cardiovascular …
-
The Bone Is Not Alone: Skeletal Muscle Is A Novel Source Of Fibroblast Growth Factor 23
… often accompanied by various pathologies. Hyperphosphatemia contributes to a range of complications, including vascular calcification, systemic inflammation, anemia, left ventricular hypertrophy, and skeletal muscle atrophy. Phosphate homeostasis is tightly regulated through a combination of …
-
Τα επίπεδα του αυξητικού παράγοντα των ινοβλαστών 23 (FGF23) και της πρωτεΐνης klotho σε σχέση με την ηλικία και τη νεφρική επαναρρόφηση φωσφόρου στην παιδική ηλικία
Background: Phosphate serum levels in children vary with age. Fibroblast Growth Factor 23 (FGF23) is a phosphaturic hormone that plays an important role in phosphate homeostasis. Klotho is the essential co-player of FGF23 that mediates the binding of FGF23 to its receptor. Data for fibroblast …
-
Phosphate as a cardiovascular risk factor: effects on vascular and endothelial function
… cardiovascular (CV) risk factors, including serum phosphate. Currently, there is no therapeutic intervention which has been shown to effectively reverse the increased CV risk in CKD. Phosphate metabolism is disordered in CKD particularly in the advanced stages (CKD 4 and 5). Even at the upper …
-
Studies of mortality risk predictors in hypertensive patients
… blood pressure variability (BPV), haematocrit, serum phosphate, serum electrolytes and indices of liver dysfunction or injury in predicting mortality in hypertensive patients. The study settings (Glasgow Blood Pressure Clinic) provided an opportunity to examine these relationships in a treated …
-
Exploring the Relationships Between Ethnicity, Health Literacy, Self-efficacy, and Self-management in Patients Receiving Maintenance Hemodialysis
… month averages of interdialytic weight gain, serum potassium, and serum phosphate. Forty-four participants from white English speaking backgrounds and 34 participants from visible minorities, with different levels in English speaking proficiency, participated. Analysis indicates an association …
-
METHODOLOGICAL ISSUES IN EVIDENCE SUMMARIES AND GUIDELINES IN MINERAL AND BONE DISORDERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
… The condition is diagnosed by abnormal serum concentrations of calcium, phosphorus, parathyroid hormone and vitamin D. These biochemical abnormalities have been linked to abnormal bone metabolism as well as cardiovascular calcifications if left untreated. Phosphate binders are known to …
-
Η ΝΕΦΡΙΚΗ ΣΥΜΜΕΤΟΧΗ ΣΤΗ ΜΙΚΡΟΔΡΕΠΑΝΟΚΥΤΤΑΡΙΚΗ ΑΝΑΙΜΙΑ
… AND HBF. OUR S/B AND S/S PATIENTS SHOWED LOWER SERUM AND URINE MAGNESIUM LEVELS THAN DID NORMAL CONTROLS. ONE THIRD OF OUR PATIENTS SHOWED HYPERURICOURIA AND A STATISTICALLY SIGNIFICANT NEGATIVE CORRELATION WAS NOTED BETWEEN SERUM URIC ACID AND ITS FRACTIONAL CLEARANCE. SERUM PHOSPHATE LEVELS …
-
Effects of phosphate binding with sevelamer carbonate on cardiovascular structure and function in patients with early chronic kidney disease
Serum phosphate has recently emerged as a cardiovascular risk factor in several populations, including patients with chronic kidney disease. Much of the adverse cardiovascular risk profile seen in chronic kidney disease can be attributed to structural heart disease, which appears to be driven by an …
-
Assessment of a Novel Phosphate Binding Therapy in Experimental Adenine-Induced Chronic Kidney Disease
Hyperphosphatemia is a hallmark of progression in chronic kidney disease (CKD) and has been linked to the development of vascular calcification (VC), which increases cardiovascular risk. Phosphate binders are prescribed to control hyperphosphatemia. Fermagate is a calcium-free, magnesium-releasing, …
-
Application and characterization of multi-modal approaches to measuring calciprotein particle responses to oral phosphate challenges in experimental chronic kidney disease
Disturbed phosphate metabolism is a hallmark of chronic kidney disease (CKD) and directly linked to the pathogenesis of cardiovascular disease (CVD) in both CKD and the general population. Calciprotein particles (CPPs) are circulating proteinaceous nanoparticles implicated in mediating phosphate …
-
Linking Osteocyte Oxygen Sensing and Biomineralization via FGG23: Implications for Chronic Kidney Disease
… hormone necessary for maintaining systemic phosphate handling, and thus bone structure and function in both rare and common disorders such as chronic kidney disease (CKD). FGF23 is a critical factor in CKD, with elevated levels causing alterations in mineral metabolism and increased odds for …
-
Molecular Genetic Analysis of FGF23 Bioactivity in the Bone-Kidney Endocrine Axis
Heritable disorders of phosphate handling are the most common cause of hypophosphatemic rickets in developed countries. Isolated renal phosphate wasting and subsequent low serum phosphate concentrations may result from a number of genetic disorders that include: autosomal dominant hypophosphatemic …
-
Hyperphosphatemia Contributes To Functional Iron Deficiency And Skeletal Muscle Wasting
… of mineral metabolism, where excess serum levels of phosphate (hyperphosphatemia) and of fibroblast growth factor 23 (FGF23) are not only viewed as biomarkers for disease severity but also exert deleterious effects towards various CKD-associated pathologies. Elevated levels of FGF23 …
-
Calciprotein Nanoparticles in the Acute Response to Phosphate Flux During Chronic Kidney Disease and Medial Vascular Calcification
Dysregulated phosphate homeostasis is a hallmark of chronic kidney disease (CKD) progression and elevated serum phosphate is an independent risk factor for cardiovascular disease (CVD). The emergence of calciprotein particles (CPP) as a likely mediator of dysregulated mineral homeostasis during CKD …
Page 1 of 3